The decrease or absence sexual desire and arousal is the alteration of the sexual sphere that women most commonly refer to in adulthood and old age. Many women can refer a decrease or absence of desire and / or arousal without having the disorder typified in the DSM-5, but that can cause discomfort, worry and relationship problems in their day to day. Libicare® is a food supplement whose ingredients could have positive effects on the improvement of sexual function in women with low desire and arousal levels. The main ingredients of Libicare® are: * Trigonella Foenum-graecum (Trigonella) (1) * Tribulus Terrestris (Tribulus) (2) * Turnera Diffusa (Damiana) (3)
The main objective is to describe the effectivity of LIBICARE® in the improvement of desire and sexual arousal in women between 45 and 65 years old, in real life. The secondary objectives of the study are: * Evaluation of the 6 domains of the EVAS-M scale at 2 and 4 months of treatment. * Assessment of the safety of LIBICARE® by collecting serious and non-serious adverse events. * Evaluation of patient satisfaction with treatment at 2 and 4 months of treatment. * Therapeutic compliance in taking the food supplement at 2 and 4 months of treatment. * Study of the hormonal variation in relation to the values of total testosterone, free testosterone and SHBG, at the beginning, at 2 months and at 4 months of treatment, in those patients in which it is determined by routine clinical practice. * To evaluate the degree of usefulness of the EVAS-M scale in clinical practice after 4 months of treatment.
Study Type
OBSERVATIONAL
Enrollment
185
Use of a standardized scale to collect clinical and patient-centered data, to assess the effectiveness of Libicare in real life in female 45-65 years old. Patients' data (baseline characteristics, clinical and outcomes) will be collected according to sites routine care.
Instituto Palacios de Salud y Medicina de la Mujer
Madrid, Spain
To describe the effectiveness of LIBICARE® in improving sexual desire and arousal in women between 45 and 65 years of age, in real life.
The effectiveness will be the increase in the score of the EVAS-M scale that will be provided to patients in the visita during the follow-up visits.
Time frame: 4 month
Evaluation of the 6 domains of the EVAS-M scale at 2 and 4 months of treatment.
Evaluation of the 6 domains of the EVAS-M scale ("Escala de Valoración de la Actividad Sexual en la mujer" in Spanish, score from 2 to 60 points) at 2 and 4 months of treatment
Time frame: at 2 and 4 months of treatment
Evaluation of the safety of LIBICARE® by collecting serious and non-serious adverse events.
The safety that will be defined by the serious and non-serious adverse reactions collected throughout the study.
Time frame: at 4 months of treatment
Evaluation of patient satisfaction with treatment at 2 and 4 months of treatment.
Evaluation of patient satisfaction with treatment using the Likert scale
Time frame: at 2 and 4 months of treatment
Therapeutic compliance in taking the food supplement at 2 and 4 months of treatment.
Therapeutic compliance will continue to be adjusted as much as possible to routine clinical practice using the Likert scale
Time frame: at 2 and 4 months of treatment
Study of the hormonal variation in relation to the values of total testosterone, free testosterone and SHBG, at the beginning, at 2 months and at 4 months of treatment, in those patients in which it is determined by routine clinical practice.
Study of the hormonal variation in relation to the values of total testosterone, free testosterone and SHBG, at the beginning, at 2 months and at 4 months of treatment, in those patients in which it is determined by routine care
Time frame: at 0, 2 and 4 months of treatment
To evaluate the degree of usefulness of the EVAS-M (ESCALA DE VALORACION DE LA ACTIVIDAD SEXUAL in Spanish) scale in clinical practice after 4 months of treatment.
Usefulness of using the EVAS-M scale in clinical practice (last visit)
Time frame: at 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.